Affluent Medical SA (FR:AFME) has released an update.
Affluent Medical has entered into multiple agreements with Edwards Lifesciences, securing a total of EUR 15 million in upfront payments for its mitral valve technologies and an equity stake. The deals include exclusive options, licensing of intellectual property for cardiac valve replacement tech, and a significant investment that makes Edwards a 9.21% shareholder in Affluent. This partnership aims to advance Affluent’s innovative medical devices, including the adjustable mitral ring Kalios™ and Epygon mitral valve.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
